Mergers & AcquisitionsBy The Online Investor Staff, updated Fri., Jan. 24, 5:13 PM
|This Slide: #2 of 100|
Slide #2. Sanofi — Synthorx, Inc.
Sanofi (NASDAQ: SNY; EURONEXT: SAN) announced today the successful completion of its acquisition of Synthorx, Inc. ("Synthorx") for $68 per share in cash.
Sanofi is a global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Co. has three segments: Pharmaceuticals, which comprises the commercial operations of its global franchises; Consumer Healthcare, which comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products; and Human Vaccines, which comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines.
Open the SNY Page at The Online Investor »
Buy (3.33 out of 4)
(ranked higher than approx. 52% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite